3D Printed Biosensors Market Size (2024 – 2030)

According to the report published by Virtue Market Research in Global 3D Printed Biosensors Market was valued at USD 4.67 Billion and is projected to reach a market size of USD 9.39 Billion by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 10.5%. Using 3D printing techniques including material extrusion, vat photopolymerization, and material jetting, 3D printed biosensors are biosensing devices made up of electrochemical, piezoelectric, and nanomechanical biosensors. Demand for 3D-printed biosensors is being driven by their high level of precision and sophisticated quality analysis. The demand for 3D Printed Biosensors in the food & beverage, agricultural, and medical & healthcare sectors is greatly influenced by its major applications in food processing, pathogen and toxin detection.

Market Drivers of 3D Printed Biosensors Market 

• Incentives provided by Government specifically in the medical field are driving market demand for health-related 3D printed biosensors – Numerous advantages of 3D printing include flexible design, durable yet lightweight components, quick prototyping, less waste, and quick design and production. As a result of these advantages, governments are taking steps to encourage the use of 3D printing in industrial settings. For instance, the AM Forward Initiative was introduced by the Biden Administration in May 2022 to encourage the use of 3D printing technologies in industrial areas. Additionally, plans to encourage and expand the use of 3D printing technologies in Chinese enterprises were revealed by the Ministry of Electronics and Information Technology of China in December 2020. Such activities will increase demand for 3D printing technologies in the medical and healthcare sector to produce biosensors for applications such as disease detection, which will favourably affect the expansion of the 3D Printed Biosensors business.

• The increase in the number of diabetic patients and the use of 3D printed biosensors is increasing market growth - The high-precision nature and advanced quality analysis provided by 3D-printed biosensors for use in diagnosing diabetics patients are driving their market demand. 

Market Challenges of 3D Printed Biosensors Market 

• 3D printers are very expensive which limits there use and hinders the market’s expansion for 3D printed biosensors:Compared to 3D printed biosensors, manually made biosensors are less expensive since the components needed for 3D printers, like filaments, need further processing before they can be used. The overall capital cost of 3D printers is increased by the use of expensive components other than filaments, such as resins, dye additives, and powder materials like nylon. The use of such components is required for high-level printing of items, and their replacement would have an impact on the operation and performance of the machines, which would have an impact on the quality of the final output. The high cost of 3D printers will limit their use in producing biosensors for the food and beverage, agriculture, and medical & healthcare industries, which would hinder the market's expansion for these products.

Market Opportunities of 3D Printed Biosensors Market 

• Demand for Wearable health tech gadgets like fitbit and diagnostic tools is increasing rapidly in developed nations which creates an opportunity in that field – The 3D Printed Biosensor Market will increase as a result of rising consumer demand for wearable health monitoring gadgets and high adoption of technologically advanced diagnostic equipment. The key drivers of industry growth in the upcoming years will be cost reduction, increased production rates, and product optimization.

3D Printed Biosensors Market Recent Developments 

• A ground-breaking method for 3D printing biosensors was developed at the University of Houston in June 2022 and involves the layer-by-layer polymerization of a resin loaded with organic semiconductors to produce tiny and biocompatible circuit boards.

• A 3D printed biosensor developed by researchers at the Weldon School of Biomedical Engineering will be able to identify important organ and tissue regions during surgical procedures in June 2021.

• In November 2020, researchers at Clarkson University created a unique bio-ink that can be utilised to create wearable biosensors for sunburn prevention that can be 3D printed and are skin-compatible.

Segmentation Analysis

3D PRINTED BIOSENSORS MARKET REPORT COVERAGE:

3D Printed Biosensors Market Segmentation – By Type 

• Electrochemical Biosensors

• Piezoelectric Biosensors

• Nanomechanical Biosensors

• Optical Biosensors

• Thermometric Biosensors

• Wearable Biosensors

• Enzyme Biosensors

• Immunosensors

3D Printed Biosensors Market Segmentation - By Wearing Type 

• Wearable

• Non-Wearable

The biosensors are typically distinguished in 2 major categories. First, the one’s which need to be worn in hand or any other part of the body, i.e., wearable in order to work. Second, the sensors which work without body contact are non-wearable sensors.

3D Printed Biosensors Market Segmentation - By Technology 

• Material Extrusion

• Vat Photopolymerization

• Material Jetting

The metal extrusion technology accounted for the biggest market share for 3D printed biosensors in 2022, and it is anticipated to expand at a CAGR of 9.7% from 2023 to 2030. Compared to other printing methods like material jetting and vat photopolymerization, metal extrusion 3D printing is more accurate, subtle, and user-friendly. Metal extrusion is also utilised for prototyping various medical equipment because of its inexpensive cost and straightforward use. The biosensors created in this way have broad applications in biomedical disciplines where they will be used to monitor glucose levels and identify diseases including diabetes, heart disease, and cancer. The demand for metal extrusion 3D printing for biosensor applications is thus predicted to develop throughout the forecast period as a result of its beneficial characteristics and cost-effectiveness, which will support sector expansion.

3D Printed Biosensors Market Segmentation - By Application 

• Food Processing
• Pathogen Detection
• Disease Diagnosis
• Toxicity Detection

Biosensors are used in a variety of industries, including the food industry, the medical profession, the marine sector, and others. They offer more stability and sensitivity when compared to conventional approaches. Monitoring, food authenticity, quality, and safety in the food processing the upkeep of food goods, their quality and safety, and their processing present a difficult challenge for the food processing business. Due to human exhaustion, traditional methods for performing chemical experiments and spectroscopy are costly and time-consuming. The food business would benefit from alternate methods of food authentication and monitoring that could be implemented in a cost-effective manner and measure food products objectively and consistently. Therefore, it would seem advantageous for biosensors to be developed in response to the desire for quick, accurate, selective, and low-cost methods.

3D Printed Biosensors Market Segmentation - By End-Use Industry 

• Food & Beverage

• Medical & Healthcare

• Agriculture

The market for 3D printed biosensors was dominated by the medical and healthcare sector in 2022, and it is anticipated to expand at a CAGR of 10.5% from 2023 to 2030. The medical & healthcare industry heavily utilises 3D printed biosensors like electrochemical, piezoelectric, and nanomechanical ones for the diagnosis and detection of diabetes, cardiovascular disease, and cancer. Because of sedentary lifestyles and environmental causes, the number of cancer patients has been increasing quickly over time. For instance, the Indian Council of Medical Research forecasts a 12% increase in cancer patients over the next five years in its November 2021 announcement. Additionally, the American Cancer Society predicts that in 2022, there will be 1.9 million new instances of cancer, a significant increase from 2021. The need for 3D biosensors for cancer diagnosis and detection applications will rise in tandem with the rise in cancer cases, positively impacting the market growth in the medical & healthcare sector throughout the course of the projected period.

3D Printed Biosensors Market Segmentation - By Region 

• North America

• Europe

• Asia Pacif

• Middle East

• Latin America

In 2022 Asia-Pacific accounted for up to 39% of the global market for 3D printed biosensors. Due to its significant application in the medical & healthcare industry for illness detection, 3D Printed Biosensors such as electrochemical, nanomechanical, and piezoelectric are in high demand and growing in the region. The prevalence of chronic diseases like diabetes is rising significantly in developed nations like China, India, and Japan. For instance, since 2009, the prevalence of diabetes has increased, reaching 8.9% in India and 10.9% in China, according to a data from the International Diabetes Federation. The same survey also predicted that by 2030, India will have 101 million cases of diabetes and China will have 140 million cases, up from 77 million cases at the current time. With such a large number of diabetes patients, India and China will experience a rise in demand for 3D Printed Biosensors for disease detection and diagnosis, which will favourably impact the development of the 3D Printed Biosensors market in the Asia-Pacific region.

Covid- 19 impact on the 3D Printed Biosensors Market – The lockdown restrictions of COVID-19 had a negative effect on the prognosis for the 3D Printed Biosensors industry since they reduced the demand and application of 3D Printed Biosensors for food processing and toxicity checking applications in the food & beverage and agricultural sectors. At the same time the industry helped majorly by helping in manufacturing and supplying of 3D sensors required for Covid 19 detection.

3D Printed Biosensors Market - Key Players 

1. Allevi Inc.

2. Advanced Solutions Life Science

3. Cellink

4. Cyfuse Biomedical

5. Aspect Biosystem Ltd.

6. OmniVision Technologies

7. Nano3d Bioscience Inc.

8. Digilab Inc

9. Regenovo Biotechnology Co. Ltd.

10. Organovo Holdings Inc.